Bioten Co., Ltd. (XKON:289170)

Bioten Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,453	1,006
Cash & Short-Term Investments	2,453	1,006
Cash Growth	143.88%	-
Accounts Receivable	1,016	1,144
Other Receivables	0.05	0.19
Receivables	1,016	1,145
Inventory	726.02	959.79
Prepaid Expenses	13.1	10.98
Other Current Assets	1.94	23.5
Total Current Assets	4,210	3,145
Property, Plant & Equipment	2,263	2,231
Long-Term Investments	53.76	46.12
Other Intangible Assets	361.59	388.41
Long-Term Deferred Charges	-	229.28
Other Long-Term Assets	161.81	119.83
Total Assets	7,050	6,160
Accounts Payable	1,290	1,334
Accrued Expenses	379.72	74.5
Short-Term Debt	830	700
Current Portion of Long-Term Debt	1,044	1,190
Other Current Liabilities	114.77	176.08
Total Current Liabilities	3,658	3,475
Long-Term Debt	572	1,139
Other Long-Term Liabilities	8.64	38.33
Total Liabilities	4,646	4,779
Common Stock	1,553	1,428
Additional Paid-In Capital	6,392	6,392
Retained Earnings	-5,697	-6,721
Comprehensive Income & Other	-	-0
Total Common Equity	2,248	1,099
Shareholders' Equity	2,404	1,381
Total Liabilities & Equity	7,050	6,160
Total Debt	2,445	3,029
Net Cash (Debt)	7.02	-2,023
Net Cash Per Share	2.26	-714.11
Filing Date Shares Outstanding	3.11	2.83
Total Common Shares Outstanding	3.11	2.83
Working Capital	551.51	-330.52
Book Value Per Share	722.56	388.00
Tangible Book Value	1,886	710.86
Tangible Book Value Per Share	606.32	250.91
Land	1,529	1,529
Buildings	647.12	647.12
Machinery	775.78	682.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.